Erectile dysfunction in patients With chronic pain treated with opioids

被引:10
作者
Ajo, Raquel [1 ]
Segura, Ana [2 ,3 ]
Inda, Maria-del-Mar [1 ,3 ]
Margarit, Cesar [3 ,4 ]
Ballester, Pura [1 ,3 ]
Martinez, Emi [5 ]
Ferrandez, Guillermina [2 ]
Sanchez-Barbie, Angel [6 ]
Peiro, Ana M. [3 ,7 ]
机构
[1] HGUA, Unidad Invest, Inst Invest Sanitaria & Bidmed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain
[2] HGUA, Unidad Androl, Alicante, Spain
[3] HGUA, Grp Neurofarmacol Aplicada Dolor & Diversidad Fun, Inst Invest Sanitaria & Bidmed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain
[4] HGUA, Unidad Dolor UDO, Alicante, Spain
[5] UMH, Observ Ocupac, Elche, Spain
[6] UMH, CIO, Elche, Spain
[7] HGUA, Unidad Farmacol Clin, Alicante, Spain
来源
MEDICINA CLINICA | 2017年 / 149卷 / 02期
关键词
Chronic pain; Erectile dysfunction; IIEF-EF; Quality of life; Quality of sexual life; MSLQ-QOL; OXIDE SYNTHASE GENE; QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; FREE TESTOSTERONE; NONCANCER PAIN; IMPACT; PREVALENCE; GUIDELINES; MANAGEMENT; IMPOTENCE;
D O I
10.1016/j.medcli.2016.12.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objective: Chronic pain is associated with comorbidities that have an impact on the quality of life of patients and, among others, affect their sexual functioning. One of the most relevant side effects of opioid analgesics is erectile dysfunction (ED), due in part to the inhibition of the gonadal pituitary-hypothalamic axis and the decline in testosterone levels. To evaluate ED and effectiveness of treatment in men with chronic pain treated with long-term opioids. Material and methods: Prospective observational study lasting 3 years, where the intensity of pain (visual analogue scale, 0-10 cm), erectile function (IIEF-EF, range 1-30 points), quality of life (EQ-VAS, 0-100 mm), quality of sexual life (MSLQ-QOL, 0-100 points), anxiety/depression (HAD, 0-21 points) and testosterone levels, was assessed in patients who reported sexual dysfunction (ED or libido modification). A 6-month follow-up was applied to each patient after administering the usual treatment in the Andrology Unit. The study was approved by the Clinical Research Ethics Committee and data were statistically analyzed with the GraphPad Prism 5 software. Results: ED was observed in 27.6% of patients (n = 105, 57 +/- 12.2 years, mean dose of morphine equivalent = 107.1 +/- 107.9 mg/day, 84.3% adjuvant analgesics). After 6 months, 42% of patients showed a significant improvement after being treated with iPDE5 (48.5%) and/or testosterone gel (81.8%), with a resolution rate of 31% (p = 0.000). A positive correlation was observed between the improvement of IIEF and quality of sexual life (55.5 +/- 25.7 points, p = 0.000), as well as anxiety (7.4 +/- 4.3 points, p = 0.048). No significant changes were observed in the levels of testosterone, in the levels of pain nor in the quality of life, which remained moderate. Conclusions: Erectile function and quality of sexual life, as well as anxiety, improved in patients treated chronically with opioids after administering andrological treatment. The management of patients with pain should include a review of their sexual health history given the significant emotional impact posed to the patient, the impact on their overall quality of life and its good clinical response to an interdisciplinary treatment. (C) 2017 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 33 条
[1]  
Ajo R, 2016, AGING MALE, P1
[2]   Opioids Increase Sexual Dysfunction in Patients With Non-Cancer Pain [J].
Ajo, Raquel ;
Segura, Ana ;
Inda, Maria-del-Mar ;
Planelles, Beatriz ;
Martinez, Luz ;
Ferrandez, Guillermina ;
Sanchez, Angel ;
Margarit, Cesar ;
Peiro, Ana-Maria .
JOURNAL OF SEXUAL MEDICINE, 2016, 13 (09) :1377-1386
[3]   Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis [J].
Baysal, Ozlem ;
Durmus, Bekir ;
Ersoy, Yuksel ;
Altay, Zuhal ;
Senel, Kazim ;
Nas, Kemal ;
Ugur, Mahir ;
Kaya, Arzu ;
Gur, Ali ;
Erdal, Akin ;
Ardicoglu, Ozge ;
Tekeoglu, Ibrahim ;
Cevik, Remzi ;
Yildirim, Kadir ;
Kamanli, Ayhan ;
Sarac, Aysegul Jale ;
Karatay, Saliha ;
Ozgocmen, Salih .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) :795-800
[4]   Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :1995-2010
[5]   Sildenafil, a novel effective oral therapy for male erectile dysfunction [J].
Boolell, M ;
GepiAttee, S ;
Gingell, JC ;
Allen, MJ .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :257-261
[6]   Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment [J].
Breivik, H ;
Collett, B ;
Ventafridda, V ;
Cohen, R ;
Gallacher, D .
EUROPEAN JOURNAL OF PAIN, 2006, 10 (04) :287-333
[7]   Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status [J].
Cakar, Engin ;
Dincer, Umit ;
Kiralp, Mehmet Zeki ;
Taskaynatan, Mehmet Ali ;
Yasar, Evren ;
Bayman, Emine Ozgur ;
Ozgul, Ahmet ;
Dursun, Hasan .
CLINICAL RHEUMATOLOGY, 2007, 26 (10) :1607-1613
[8]   The burden of musculoskeletal diseases in the general population of Spain: results from a national survey [J].
Carmona, L ;
Ballina, J ;
Gabriel, R ;
Laffon, A .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (11) :1040-1045
[9]  
Centre NI, 2009, PRESCR DISP COMM STA
[10]   Physician-patient dialogue and clinical evaluation of erectile dysfunction [J].
Chun, J ;
Carson, CC .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (02) :249-+